在IBD中优化药物定位:临床预测因素,生物标志物和个性化治疗的实用方法
Irene Marafini1,2, Silvia Salvatori1, Antonio Fonsi1
1Gastroenterology Unit, Fondazione Policlinico Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.
Biomedicines
|January 28, 2026
概括
炎症性肠病 (IBD) 治疗正在通过向疗法推进. 个性化医疗旨在将最好的治疗方法与个体患者相匹配,以获得更好的结果.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 炎症性肠病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),是慢性免疫媒介的胃肠道疾病.
- 最近了解IBD免疫和分子途径的进展导致了新的生物和小分子疗法.
研究的目的:
- 审查有关IBD药物定位的现有证据,重点关注生物药物和小分子.
- 检查针对个性化治疗策略的新兴生物标志物和临床预测因素.
- 讨论实施IBD精准医学的挑战.
主要方法:
- 关于IBD药物定位的当前证据的全面文献综述.
- 对新出现的生物标志物和治疗反应的临床预测因素的分析.
- 讨论影响治疗决策的现实世界因素.
主要成果:
- 治疗IBD的治疗格局已经发生了变化,有针对性的药物改善了结果.
- IBD异质性需要根据临床特征和生物标志物进行个性化治疗选择.
- 生物标志物和临床预测因素对于优化治疗选择和时间至关重要.
结论:
- 个性化,基于预测的策略旨在优化IBD治疗和改变疾病的过程.
- 需要进一步的研究来将精准医学纳入常规IBD护理.
- 尽管取得了进展,但在广泛实施个性化IBD疗法方面仍然存在挑战.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
499
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
499
Combination Therapies and Personalized Medicine
6.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.1K
Maslow's Humanistic Approach on Personality
1.0K
Abraham Maslow, a prominent figure in humanistic psychology, developed a theory centered on self-actualization, which he placed at the top of his hierarchy of needs. According to Maslow, self-actualization represents achieving one's full potential and is a rare accomplishment attained by approximately 2% of the population. Maslow identified notable historical figures such as Thomas Jefferson, Mahatma Gandhi, Helen Keller, and Martin Luther King Jr. as examples of self-actualized...
1.0K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
478
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
478
Drug Therapy
269
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
269
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
528
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
528


